At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,500 enrolled
Drug / intervention
DXA and CT-scanother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Bone Fragility Evaluation by Dual X-Ray Absorptiometry (DXA) and CT-scan (vertebral Fracture and Scanographic Bone Attenuation Coefficient of the First Lumbar Vertebra SBAC-L1) in Obese Patients
In Brief
An observational study evaluating DXA and CT-scan for Obesity and Bariatric Surgery Candidate. Completed, enrolled 1,500 participants across 1 site.
Detailed Summary
This research will study the bone fragility in obese patients, on DXA and CT-scan, in a transversal study. The investigators want also to study the specific risk factors of bone fragility in these obese patients (relationship between body composition on whole body on DXA, fat mass and its location, lean mass, weight loss after surgery and SBAC-L1), to improve the bone screening.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsObesity, Bariatric Surgery Candidate
CountriesFrance
CollaboratorsCentre Hospitalier de Toul Saint Charles
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedNov 2019
Enrollment StartFeb 2020
Primary CompletionAug 2021
Study CompletionAug 2021
TodayJul 2026
First PostedNov 22, 2019
Enrollment StartFeb 23, 2020
Primary CompletionAug 20, 2021
Study CompletionAug 23, 2021
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 6.6 years ago
Interventions
DXA and CT-scanother
DXA and CT-scan are usually performed during the following of these patients before bariatric surgery